The first clinical trial of BC-821 as a cancer therapy
Latest Information Update: 21 Feb 2022
At a glance
- Drugs BC 821 (Primary)
- Indications Cancer
- Focus Adverse reactions
- 10 Nov 2015 New trial record
- 06 Nov 2015 The company is planning to initiate this trial in 2016, according to a BioCancell media release.